D Liu, Y Mao, L Ding, XA Zeng - Trends in Food Science & Technology, 2019 - Elsevier
Background Dihydromyricetin (DMY) is an important plant flavonoid, which has received great attention due to its health-benefiting activities, including antioxidant, antimicrobial, anti …
Cancer is one of the biggest challenges facing medicine and its cure is regarded to be the Holy Grail of medicine. Therapy in cancer is consisted as various artificial cytotoxic agents …
T Zeng, Y Song, S Qi, R Zhang, L Xu, P Xiao - Journal of …, 2023 - Elsevier
Ethnopharmacological relevance Vine tea is a popular folk tea that has been consumed in China for more than 1200 years. It is often used in ethnic medicine by ethnic groups in …
J Chen, X Wang, T Xia, Y Bi, B Liu, J Fu… - Biomedicine & …, 2021 - Elsevier
Recent studies demonstrated that dihydromyricetin (DHM) has prominent therapeutic effects on liver injury and liver cancer. By summarizing the current preclinical in vitro and in vivo …
H Li, Q Li, Z Liu, K Yang, Z Chen… - Evidence‐Based …, 2017 - Wiley Online Library
Dihydromyricetin is a flavonoid isolated from Ampelopsis grossedentata, which is traditionally used in China. Dihydromyricetin exhibits health‐benefiting activities with …
The mammalian target of rapamycin (mTOR) is a highly conserved serine/threonine-protein kinase, which regulates many biological processes related to metabolism, cancer, immune …
Y Wu, Y Xiao, Y Yue, K Zhong, Y Zhao, H Gao - Food Hydrocolloids, 2020 - Elsevier
Abstract 2R, 3R-Dihydromyricetin (DMY) is a natural flavonoid that has versatile biological activities. However, due to its poor water solubility and low chemical stability, its applications …
J Wu, Z Xiao, H Li, N Zhu, J Gu, W Wang, C Liu… - Cancers, 2022 - mdpi.com
Simple Summary With the advancements in diagnosis and treatment technology, the mortality of patients with cancer is gradually decreasing. However, further curbing cancer …